KRAS and neoplasm: In particular, the BRAF V600E mutation (rs113488022) in exon 15, which occurs in 8-10% of colorectal tumors and is mutually exclusive with KRAS mutations, was found to be associated with a more aggressive tumor phenotype, lymph node metastasis, and high microsatellite instability (MSI) [26].